《西维斯健康CVS Health（CVS）2024年10-K年度报告「NYSE」（英文版）（320页）.pdf》由会员分享，可在线阅读，更多相关《西维斯健康CVS Health（CVS）2024年10-K年度报告「NYSE」（英文版）（320页）.pdf（320页珍藏版）》请在三个皮匠报告上搜索。

1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM 10-K (Mark One)ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended December 31,2024or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 19

2、34For the transition period from _ to_Commission file number:001-01011CVS HEALTH CORPORATION(Exact name of registrant as specified in its charter)Delaware05-0494040(State or other jurisdiction of incorporation or organization)(I.R.S.Employer Identification No.)One CVS Drive,Woonsocket,Rhode Island02

3、895(Address of principal executive offices)(Zip Code)Registrants telephone number,including area code:(401)765-1500Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading Symbol(s)Name of each exchange on which registeredCommon Stock,par value$0.01 per shareCVSNew York S

4、tock ExchangeSecurities registered pursuant to Section 12(g)of the Act:NoneIndicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.YesNoIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Sec

5、tion 15(d)of the Act.YesNoIndicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934during the preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has

6、been subject to such filingrequirements for the past 90 days.YesNoIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulation S-T(232.405 of this chapter)during the preceding 12 months(or for such s